, Decision_act (EU) 1980/1283

In forcesince 25 Nov 1980

COMMISSION DECISION of 25 November 1980 relating to a proceeding under Article 85 of the EEC Treaty (IV/29.702 : Johnson & Johnson) (Only the English and German texts are authentic) (80/1283/EEC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community and in particular Article 85 thereof,

Having regard to Council Regulation No 17 of 6 February 1962 (1), and in particular Articles 3 and 15 thereof,

Having regard to the application submitted to the Commission, pursuant to Article 3 of Regulation No 17, on 22 March 1979 on behalf of Eurim Pharm GmbH of Piding, Federal Republic of Germany,

Having regard to the Commission Decision of 21 June 1979 to initiate proceedings in this case,

Having heard the undertakings concerned in accordance with Article 19 of Regulation No 17 and having offered the undertakings concerned an opportunity of being heard in accordance with Commission Regulation No 99/63/EEC of 25 July 1963 (2), which opportunity the undertakings declined,

Having heard the opinion of the Advisory Committee on Restrictive Practices and Dominant Positions delivered pursuant to Article 10 of Regulation No 17 on 30 November 1979,

Whereas:

I.

THE FACTS 1. The subject of these proceedings is the practices of Ortho Pharmaceutical Ltd on the one hand, and Cilag Chemie GmbH (Alsbach) and Cilag Chemie AG (Schaffhausen) on the other hand, all three being subsidiaries of Johnson & Johnson Inc., who, by imposing restrictions on dealers in the United Kingdom and in Germany, hindered exports of Gravindex pregnancy tests, in particular from the United Kingdom to the German importer Eurim Pharm GmbH.

A. The undertakings

Johnson & Johnson Inc., New Brunswick, USA

2.

Johnson & Johnson Inc. (hereinafter called "Johnson & Johnson") is one of the largest pharmaceutical and medical manufacturers in the world. Its turnover of $ 2 914 millions in 1977 was divided as follows (in millions of dollars): >PIC FILE= "T0013495">

Johnson & Johnson has subsidiaires world-wide. In Europe it has 38 subsidiaries in 14 countries, including 28 subsidiaries in all Member States of the EEC except Luxembourg.

There is no central European office of Johnson & Johnson. The subsidiaries are responsible directly to the parent company in the USA. The activities of the European subsidiaries are limited to serving their respective national markets. (1)OJ No 13, 21.2.1962, p. 204/62. (2)OJ No 127, 20.8.1963, p. 2268/63. >PIC FILE= "T0013496">